Tetra Therapeutics
Florham Park, US · 2 known investors
Find your way into Tetra Therapeutics
Sign up to see every warm intro you have to Tetra Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tetra Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tetra Therapeutics (Tetra Discovery Partners) was a discovery-based pharmaceutical company developing clinical programs including treatments for Fragile X Syndrome. It was acquired by Shionogi & Co. in 2020, and its former clinical trials and research programs are now managed by Shionogi Inc., a U.S. subsidiary.
Investors · 2
Frequently asked questions
- What does Tetra Therapeutics do?
- Tetra Therapeutics (Tetra Discovery Partners) was a discovery-based pharmaceutical company developing clinical programs including treatments for Fragile X Syndrome. It was acquired by Shionogi & Co. in 2020, and its former clinical trials and research programs are now managed by Shionogi Inc., a U.S. subsidiary.
- Who are Tetra Therapeutics's investors?
- Tetra Therapeutics's investors include Dolby Family Ventures, Invest Michigan.
- Where is Tetra Therapeutics headquartered?
- Tetra Therapeutics is headquartered in Florham Park, US.